Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/27/2025

Chlamydia Treatment Guidelines

First-Line Treatment Options

  • The Centers for Disease Control and Prevention recommends azithromycin 1 g orally in a single dose or doxycycline 100 mg orally twice daily for 7 days as first-line treatment for uncomplicated chlamydial infection, with microbial cure rates of approximately 97% and 98%, respectively 1, 2, 3
  • Azithromycin has advantages including single-dose therapy, directly observed treatment possible, and better compliance, making it particularly useful when compliance with multi-day regimens is questionable 1, 3
  • Doxycycline has advantages including lower cost and extensive clinical experience, with a microbial cure rate of approximately 98% 1

Alternative Treatment Options

  • The Centers for Disease Control and Prevention recommends erythromycin base 500 mg orally four times a day for 7 days, erythromycin ethylsuccinate 800 mg orally four times a day for 7 days, ofloxacin 300 mg orally twice a day for 7 days, and levofloxacin 500 mg orally once daily for 7 days as alternative treatments for chlamydial infection 1, 2

Clinical Considerations

  • A meta-analysis of 12 randomized clinical trials showed azithromycin and doxycycline are equally efficacious for genital chlamydial infections, with similar rates of mild-to-moderate side effects 1
  • Patient compliance and cost considerations should be taken into account when selecting a treatment, with azithromycin preferred when compliance is a concern and doxycycline generally less expensive 1, 3

Implementation Recommendations

  • Medications should be dispensed on-site when possible, with the first dose directly observed to maximize compliance, and patients should abstain from sexual intercourse for 7 days after single-dose therapy or until completion of a 7-day regimen 1
  • Patients should abstain from sexual intercourse until all sex partners are treated, and test-of-cure is not recommended for patients treated with the recommended regimens unless therapeutic compliance is questionable, symptoms persist, or reinfection is suspected 1

Follow-Up Recommendations

  • Consider retesting women approximately 3 months after treatment due to high risk of reinfection, and test-of-cure is not recommended unless therapeutic compliance is questionable, symptoms persist, or reinfection is suspected 1, 3

Partner Management

  • All sex partners from the previous 60 days should be evaluated, tested, and treated, and if the last sexual contact was >60 days before diagnosis, the most recent partner should still be treated 4

Special Populations

  • Azithromycin and doxycycline are not recommended during pregnancy, and recommended treatment during pregnancy is erythromycin base 500 mg orally four times daily for 7 days, with amoxicillin 500 mg orally three times daily for 7-10 days as an alternative 5, 6
  • Patients with HIV should receive the same treatment regimens as those who are HIV-negative 2, 7

Chlamydia Treatment Efficacy and Management

Treatment Options and Efficacy

  • Gastrointestinal side effects with erythromycin often lead to poor compliance, making it a less desirable alternative, as reported by the MMWR Recommendations and Reports 8

Special Considerations

  • No unique, non-redundant facts with citations are available in the provided article for this section.

Treatment for Chlamydia trachomatis

Special Populations

  • Amoxicillin 500 mg orally three times a day for 7 days is an alternative option during pregnancy, as recommended by the Centers for Disease Control and Prevention 9
  • Treatment failure is uncommon with recommended regimens, with failure rates of 0-3% for males and 0-8% for females, according to the Centers for Disease Control and Prevention 9, 10

REFERENCES